Literature DB >> 29386255

HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling.

Silvia Albertini1, Irene Lo Cigno1, Federica Calati1, Marco De Andrea1,2, Cinzia Borgogna1, Valentina Dell'Oste2, Santo Landolfo2, Marisa Gariglio3.   

Abstract

Although it is clear that high-risk human papillomaviruses (HPVs) can selectively infect keratinocytes and persist in the host, it still remains to be unequivocally determined whether they can escape antiviral innate immunity by interfering with pattern recognition receptor (PRR) signaling. In this study, we have assessed the innate immune response in monolayer and organotypic raft cultures of NIKS cells harboring multiple copies of episomal HPV18 (NIKSmcHPV18), which fully recapitulates the persistent state of infection. We show for the first time, to our knowledge, that NIKSmcHPV18, as well as HeLa cells (a cervical carcinoma-derived cell line harboring integrated HPV18 DNA), display marked downregulation of several PRRs, as well as other PRR downstream effectors, such as the adaptor protein stimulator of IFN genes and the transcription factors IRF1 and 7. Importantly, we provide evidence that downregulation of stimulator of IFN genes, cyclic GMP-AMP synthase, and retinoic acid-inducible gene I mRNA levels occurs at the transcriptional level through a novel epigenetic silencing mechanism, as documented by the accumulation of repressive heterochromatin markers seen at the promoter region of these genes. Furthermore, stimulation of NIKSmcHPV18 cells with salmon sperm DNA or poly(deoxyadenylic-deoxythymidylic) acid, two potent inducers of PRR signaling, only partially restored PRR protein expression. Accordingly, the production of IFN-β and IFN-λ1 was significantly reduced in comparison with the parental NIKS cells, indicating that HPV18 exerts its immunosuppressive activity through downregulation of PRR signaling. Altogether, our findings indicate that high-risk human papillomaviruses have evolved broad-spectrum mechanisms that allow simultaneous depletion of multiple effectors of the innate immunity network, thereby creating an unreactive cellular milieu suitable for viral persistence.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29386255     DOI: 10.4049/jimmunol.1701536

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.

Authors:  Irene Lo Cigno; Federica Calati; Cinzia Borgogna; Alessandra Zevini; Silvia Albertini; Licia Martuscelli; Marco De Andrea; John Hiscott; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

2.  Apoptotic caspases suppress an MDA5-driven IFN response during productive replication of human papillomavirus type 31.

Authors:  Ning Huang; Des'ree Groover; Blossom Damania; Cary Moody
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-11       Impact factor: 12.779

3.  Extracellular Vesicle Release Promotes Viral Replication during Persistent HCV Infection.

Authors:  Yucel Aydin; Ali Riza Koksal; Venu Reddy; Dong Lin; Hanadi Osman; Zahra Heidari; Sadeq Mutlab Rhadhi; William C Wimley; Mansour A Parsi; Srikanta Dash
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

Review 4.  Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins.

Authors:  Irene Lo Cigno; Federica Calati; Silvia Albertini; Marisa Gariglio
Journal:  Pathogens       Date:  2020-04-17

5.  Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection.

Authors:  Brittany L Uhlorn; Robert Jackson; Shuaizhi Li; Shauna M Bratton; Koenraad Van Doorslaer; Samuel K Campos
Journal:  PLoS Pathog       Date:  2020-11-30       Impact factor: 6.823

6.  Human Beta Papillomavirus Type 8 E1 and E2 Proteins Suppress the Activation of the RIG-I-Like Receptor MDA5.

Authors:  Stephanie Rattay; Martin Hufbauer; Christian Hagen; Bastian Putschli; Christoph Coch; Baki Akgül; Gunther Hartmann
Journal:  Viruses       Date:  2022-06-22       Impact factor: 5.818

Review 7.  Regulation of the Innate Immune Response during the Human Papillomavirus Life Cycle.

Authors:  Cary A Moody
Journal:  Viruses       Date:  2022-08-17       Impact factor: 5.818

8.  Bovine Delta Papillomavirus E5 Oncoprotein Interacts With TRIM25 and Hampers Antiviral Innate Immune Response Mediated by RIG-I-Like Receptors.

Authors:  Francesca De Falco; Anna Cutarelli; Ivan Gentile; Pellegrino Cerino; Valeria Uleri; Adriana Florinela Catoi; Sante Roperto
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.